# Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy

> **NCT01521546** · NA · COMPLETED · sponsor: **Subha Raman** · enrollment: 42 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** eplerenone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01521546
- **Lead sponsor:** Subha Raman
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521546, "Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01521546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*